Haema and BPC, two businesses Grifols acquired in 2018, are owned by Scranton Enterprises BV, an investment vehicle controlled by former company executives, including family members. Gotham said ...

The family that owns Spanish drugmaker Grifols and private equity firm Brookfield are considering whether to take the company private in a deal that could be worth around €5.5 billion (almost $6 ...

where Rigel secured approval for the drug as Tavalisse in 2018. It was the first non-plasma product that the Grifols' flagship bioscience division launched in the European market. Grifols has been ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF ...